AHCO
AdaptHealth Corp.
NASDAQ · Healthcare · Medical - Devices · US
$5.88
−2.33%Year over year
Reported trailing growth
- Revenue
- +14.6%
- EBITDA
- -53.5%
- EBIT
- —
- EPS
- —
- Free cash flow
- -57.8%
- Operating cash flow
- +5.6%
Forward estimates
Based on analyst estimates
- Revenue
- -1.2%
- EBITDA
- +90.6%
- EPS
- +98.6%
Three-year CAGR
- Revenue
- +3.0%
- EBITDA
- -5.4%
- EBIT
- -0.7%
- Net income
- —
- EPS
- —
- Free cash flow
- +23.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026